高级检索
当前位置: 首页 > 详情页

TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Capital Med Univ, Beijing Friendship Hosp, Beijing Inst Trop Med, Beijing 100050, Peoples R China [2]Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China [3]Tsinghua Univ, Natl Engn Res Ctr Prot Technol, Beijing 100084, Peoples R China [4]Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China [5]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Etiol & Carcinogenesis, Beijing 100021, Peoples R China
出处:
ISSN:

摘要:
Mutant p53 (mtp53) can exert cancer-promoting activities via "gain-of-function", which has become a popular research target. Although lots of researchers focus on the tumor-suppressor role for p53, the regulation of mutant p53 remains unknown. Here, we report a mechanism by which mtp53 regulate the transcription of Rab coupling protein (RCP) to influence lung cancer behavior. First, we show that RCP is specifically expressed at high levels in lung cancer tissues and cells, and RCP knockout suppresses tumor growth and metastasis. Further mass spectrometry and functional analysis identify that Sp1, Sp3 and Stat3 are the transcriptional activators of RCP. Moreover, p53 is involved in modulating RCP expression in an Sp1/3 dependent manner. Mechanistically, in contrast to wild-type p53 suppression of RCP transcription by decreasing Sp1/3 proteins, TP53 mutations have changed on Sp1/3 expression via "loss-of-function". Surprisingly, the DNA contact mutants of p53 further robustly enhance their binding ability with Sp1/3 to drive RCP expression through the "gain-of-function" activity. Collectively, we reveal a mechanism by which p53 regulating the transcription of RCP to influence lung cancer progression, which provides new insights for treating p53 mutant lung cancer.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 肿瘤学 1 区 遗传学 2 区 细胞生物学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 遗传学 2 区 细胞生物学 2 区 肿瘤学
JCR分区:
出版当年[2020]版:
Q1 GENETICS & HEREDITY Q1 CELL BIOLOGY Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 ONCOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 GENETICS & HEREDITY Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Capital Med Univ, Beijing Friendship Hosp, Beijing Inst Trop Med, Beijing 100050, Peoples R China [2]Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China [3]Tsinghua Univ, Natl Engn Res Ctr Prot Technol, Beijing 100084, Peoples R China [4]Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China [3]Tsinghua Univ, Natl Engn Res Ctr Prot Technol, Beijing 100084, Peoples R China [4]Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)